These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 35029211)

  • 1. Programmed death 1 monoclonal antibody helped to treat mixed chimeric and reactivation of Epstein-Barr virus in a patient with adult-onset chronic active Epstein-Barr virus infection after allogeneic hematopoietic stem cell transplantation: A case report.
    You Y; Wang J; Wang Z
    Medicine (Baltimore); 2022 Jan; 101(2):e28542. PubMed ID: 35029211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Late-onset posttransplant Epstein-Barr virusrelated lymphoproliferative disease after cord blood transplantation for chronic active Epstein Barr virus infection: A case report.
    Yamamoto M; Shindo M; Funayama T; Sumi C; Saito T; Toki Y; Hatayama M; Imadome KI; Mizukami Y; Okumura T
    Medicine (Baltimore); 2022 Mar; 101(12):e29055. PubMed ID: 35357349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case series of CAEBV of children and young adults treated with reduced-intensity conditioning and allogeneic bone marrow transplantation: a single-center study.
    Watanabe Y; Sasahara Y; Satoh M; Looi CY; Katayama S; Suzuki T; Suzuki N; Ouchi M; Horino S; Moriya K; Nanjyo Y; Onuma M; Kitazawa H; Irie M; Niizuma H; Uchiyama T; Rikiishi T; Kumaki S; Minegishi M; Wada T; Yachie A; Tsuchiya S; Kure S
    Eur J Haematol; 2013 Sep; 91(3):242-248. PubMed ID: 23734904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Massive pericardial effusion due to chronic active Epstein-Barr virus infection successfully treated with PD-1 blockade: A case report.
    Pi Y; Wang J; Wang Z
    Medicine (Baltimore); 2022 Aug; 101(34):e30298. PubMed ID: 36042605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salvage Human Leukocyte Antigen-Haploidentical Hematopoietic Cell Transplant With Posttransplant Cyclophosphamide for Graft Failure in a Patient With Chronic Active Epstein-Barr Virus Infection.
    Nakaya Y; Koh H; Harada N; Okamura H; Misugi T; Suekane T; Tachibana D; Kimura H; Hino M; Nakamae H
    Exp Clin Transplant; 2023 Feb; 21(2):184-188. PubMed ID: 36919727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haploidentical hematopoietic stem cell transplantation for adult patients with Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis.
    Li Z; Wang Y; Wang J; Zhang J; Wang Z
    Leuk Lymphoma; 2018 Jan; 59(1):77-84. PubMed ID: 28573910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NK-cell post-transplant lymphoproliferative disease successfully treated by second allogenic hematopoietic stem cell transplantation in chronic active Epstein-Barr virus infection.
    Shibata S; Takiuchi Y; Kawasaki N; Okamoto Y; Inano S; Fukunaga A; Tabata S; Arai A; Imadome KI; Kitano T
    Int J Hematol; 2022 Apr; 115(4):595-599. PubMed ID: 35001347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic active Epstein-Barr virus infection manifesting as coronary artery aneurysm and uveitis.
    Xiao H; Hu B; Luo R; Hu H; Zhang J; Kuang W; Zhang R; Li L; Liu G
    Virol J; 2020 Oct; 17(1):166. PubMed ID: 33121509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful HLA-haploidentical stem cell transplantation with post-transplant cyclophosphamide in an older patient with chronic active Epstein-Barr virus infection.
    Maegaki M; Kawamura K; Hara K; Hosoda R; Suzuki S; Hosoda Y; Imadome KI; Motokura T; Fukuda T
    Int J Hematol; 2022 Oct; 116(4):630-634. PubMed ID: 35438460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon alpha as antiviral therapy in chronic active Epstein-Barr virus disease with interstitial pneumonia - case report.
    Roliński J; Grywalska E; Pyzik A; Dzik M; Opoka-Winiarska V; Surdacka A; Maj M; Burdan F; Pirożyński M; Grabarczyk P; Starosławska E
    BMC Infect Dis; 2018 Apr; 18(1):190. PubMed ID: 29678144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epstein-Barr virus-specific cytokine-induced killer cells for treatment of Epstein-Barr virus-related malignant lymphoma.
    Pfeffermann LM; Pfirrmann V; Huenecke S; Bremm M; Bonig H; Kvasnicka HM; Klingebiel T; Bader P; Rettinger E
    Cytotherapy; 2018 Jun; 20(6):839-850. PubMed ID: 29754771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epstein-Barr virus (EBV) reactivation in allogeneic stem-cell transplantation: relationship between viral load, EBV-specific T-cell reconstitution and rituximab therapy.
    Clave E; Agbalika F; Bajzik V; Peffault de Latour R; Trillard M; Rabian C; Scieux C; Devergie A; Socié G; Ribaud P; Adès L; Ferry C; Gluckman E; Charron D; Esperou H; Toubert A; Moins-Teisserenc H
    Transplantation; 2004 Jan; 77(1):76-84. PubMed ID: 14724439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes of programmed death protein-1 inhibitors treatment of chronic active Epstein Barr virus infection: A single center retrospective analysis.
    Ma Y; Zhang P; Bao Y; Luo H; Wang J; Huang L; Zheng M
    Front Immunol; 2023; 14():1093719. PubMed ID: 36969150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Chronic active Epstein-Barr virus infection with marked pericardial effusion successfully treated with allogeneic peripheral blood stem cell transplantation].
    Matsui S; Takeda Y; Isshiki Y; Yamazaki A; Nakao S; Takaishi K; Nagao Y; Hasegawa N; Togasaki E; Shimizu R; Kawajiri C; Sakai S; Mimura N; Takeuchi M; Ohwada C; Sakaida E; Iseki T; Imadome K; Nakaseko C
    Rinsho Ketsueki; 2016 May; 57(5):624-9. PubMed ID: 27263789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Difficult Balance Between EBV Treatment and Posttransplant Immunosuppression: A Successful Transplant in a Child With Recurrent Epstein-Barr Virus-Induced Hemophagocytic Lymphohistiocytosis.
    Fałkowska A; Prądzyńska K; Drabko K
    Transplant Proc; 2021; 53(6):2035-2039. PubMed ID: 33933286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful control of Epstein-Barr virus (EBV)-infected cells by allogeneic nonmyeloablative stem cell transplantation in a patient with the lethal form of chronic active EBV infection.
    Uehara T; Nakaseko C; Hara S; Harima A; Ejiri M; Yokota A; Saito Y; Nishimura M
    Am J Hematol; 2004 Aug; 76(4):368-72. PubMed ID: 15282671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Case Report: A Case of Epstein-Barr Virus-Associated Acute Liver Failure Requiring Hematopoietic Cell Transplantation After Emergent Liver Transplantation.
    Nakajima K; Hiejima E; Nihira H; Kato K; Honda Y; Izawa K; Kawabata N; Kato I; Ogawa E; Sonoda M; Okamoto T; Okajima H; Yasumi T; Takita J
    Front Immunol; 2022; 13():825806. PubMed ID: 35154146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allogeneic peripheral blood stem cell transplantation for the treatment of chronic active Epstein-Barr virus infection.
    Fujii N; Takenaka K; Hiraki A; Maeda Y; Ikeda K; Shinagawa K; Ashiba A; Munemasa M; Sunami K; Hiramatsu Y; Ishimaru F; Niiya K; Yoshino T; Harada M
    Bone Marrow Transplant; 2000 Oct; 26(7):805-8. PubMed ID: 11042666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allogeneic hematopoietic stem cell transplantation for Epstein-Barr virus-associated T/natural killer-cell lymphoproliferative disease in Japan.
    Sato E; Ohga S; Kuroda H; Yoshiba F; Nishimura M; Nagasawa M; Inoue M; Kawa K
    Am J Hematol; 2008 Sep; 83(9):721-7. PubMed ID: 18626884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unrelated cord blood transplantation for adult-onset EBV-associated T-cell and NK-cell lymphoproliferative disorders.
    Onishi Y; Onodera K; Fukuhara N; Kato H; Ichikawa S; Fujiwara T; Yokoyama H; Yamada-Fujiwara M; Harigae H
    Int J Hematol; 2022 Jun; 115(6):873-881. PubMed ID: 35274195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.